Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect
Article in Annals of Hematology (August 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
AXL Inhibition Represents a Novel Therapeutic Approach in BCR‐ABL Negative Myeloproliferative Neoplasms
Article in HemaSphere (August 2021)